Macrogen, Inc. (KOSDAQ:038290)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,840
+100 (0.60%)
Dec 10, 2025, 3:30 PM KST
14.56%
Market Cap181.49B
Revenue (ttm)179.98B
Net Income (ttm)-700.38M
Shares Out10.84M
EPS (ttm)-65.98
PE Ration/a
Forward PE23.28
Dividend300.00 (1.79%)
Ex-Dividend DateDec 29, 2025
Volume23,386
Average Volume36,050
Open16,750
Previous Close16,740
Day's Range16,270 - 16,900
52-Week Range14,710 - 18,000
Beta0.68
RSI63.27
Earnings DateFeb 13, 2026

About Macrogen

Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally. It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In S... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 475
Stock Exchange KOSDAQ
Ticker Symbol 038290
Full Company Profile

Financial Performance

In 2024, Macrogen's revenue was 135.78 billion, an increase of 2.24% compared to the previous year's 132.80 billion. Losses were -7.60 billion, -54.78% less than in 2023.

Financial Statements

News

There is no news available yet.